We are live on ! Find out more
LXRX icon

Lexicon Pharmaceuticals
LXRX

137 hedge funds and large institutions have $1.41B invested in Lexicon Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 44 increasing their positions, 33 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 33

15% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 20

1% more funds holding

Funds holding: 135 → 137 (+2)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.4% less ownership

Funds ownership: 109.14% → 108.74% (-0.4%)

25% less capital invested

Capital invested by funds: $1.89B → $1.41B (-$478M)

88% less call options, than puts

Call options by funds: $1.77M | Put options by funds: $14.2M

Holders
137
Holders Change
+2
Holders Change %
+1.48%
% of All Funds
3.42%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
23
Increased
44
Reduced
33
Closed
20
Calls
$1.77M
Puts
$14.2M
Net Calls
-$12.4M
Net Calls Change
-$26.6M

Top Buyers

1
KCM
Kornitzer Capital Management
Kansas
+$11.3M
2
Bank of America
Bank of America
North Carolina
+$6.06M
3
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$5.18M
4
VOYA Investment Management
VOYA Investment Management
Georgia
+$4.15M
5
PA
Pinnacle Associates
New York
+$2.69M

Top Sellers

1
Norges Bank
Norges Bank
Norway
-$12.5M
2
KCM
Kingdon Capital Management
New York
-$7.96M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$5.61M
4
Millennium Management
Millennium Management
New York
-$4.56M
5
CCI
Columbus Circle Investors
-$3.94M
Name Holding Trade Value Shares
Change 		Change in
Stake
CHP
126
Cable Hill Partners
Oregon
$7K -$192 -13 -2%
LJHT
127
Laurie J. Hall Trustee
$4.18K – – –
PHK
128
Point72 Hong Kong
Hong Kong
$3K +$3.77K +255 New
ASN
129
Advisory Services Network
Georgia
$2K – – –
BFEC
130
Benjamin F. Edwards & Company
Missouri
$2K +$2.21K +150 New
YWP
131
YorkBridge Wealth Partners
New York
$2K +$2.78K +188 New
US Bancorp
132
US Bancorp
Minnesota
$1K -$15.9K -1,077 -91%
HCM
133
Highlander Capital Management
New Jersey
$1K – – –
IWM
134
IHT Wealth Management
Illinois
$1K – – –
SEI Investments
135
SEI Investments
Pennsylvania
$1K – – –
QIM
136
Quantitative Investment Management
Virginia
– -$2.3M -140,100 Closed
OAM
137
Oxford Asset Management
United Kingdom
– -$1.73M -104,837 Closed
Macquarie Group
138
Macquarie Group
Australia
– -$1.72M -104,566 Closed
Ameriprise
139
Ameriprise
Minnesota
– -$1.26M -76,633 Closed
AR
140
Advisory Research
Illinois
– -$1.23M -74,907 Closed
VRS
141
Virginia Retirement Systems
Virginia
– -$604K -36,700 Closed
ARTA
142
A.R.T. Advisors
New York
– -$565K -34,400 Closed
BA
143
Boston Advisors
Massachusetts
– -$524K -31,855 Closed
MAP
144
Moody Aldrich Partners
Massachusetts
– -$509K -30,930 Closed
3C
145
361 Capital
Colorado
– -$409K -24,874 Closed
JG
146
Jefferies Group
New York
– -$273K -16,593 Closed
FMT
147
First Mercantile Trust
Tennessee
– -$201K -12,212 Closed
PPA
148
Parametric Portfolio Associates
Washington
– -$182K -11,066 Closed
DADC
149
D.A. Davidson & Co
Montana
– -$75K -4,600 Closed
QT
150
Quantbot Technologies
New York
– -$72K -4,403 Closed
3 4 5
6
7

LXRX Hedge Fund Activity: Q3 2017 in Review

137 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Lexicon Pharmaceuticals (LXRX) for Q3 2017, worth a combined $1.41B — down 25% from $1.89B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new LXRX positions and 20 closed out — a net gain of 3 holders — while 44 added to existing stakes and 33 trimmed.

The largest buyer was Kornitzer Capital Management, opening a new position worth an estimated $11.3M. The largest seller was Norges Bank, cutting an estimated $12.5M.

  • 137 institutional investors held Lexicon Pharmaceuticals (LXRX) as of Q3 2017, up from 135 in Q2 2017.
  • Funds reported $1.41B of Lexicon Pharmaceuticals stock for Q3 2017, down 25% quarter-over-quarter.
  • 23 funds opened new Lexicon Pharmaceuticals positions in Q3 2017 and 20 closed out, a net change of +3 holders.
  • The largest Lexicon Pharmaceuticals buyer in Q3 2017 was Kornitzer Capital Management, an estimated $11.3M added.
  • The largest Lexicon Pharmaceuticals seller in Q3 2017 was Norges Bank, an estimated $12.5M sold.

Based on aggregated 13F filings for Q3 2017.